This change frees researchers to study cannabis products that most consumers encounter when buying medical marijuana – which could accelerate its Read More
September 15, 2026
Chris Wright’s passion for the Vertical Corridor & Pierrakakis’s jab at Tsipras The post The blue MPs’ coquettish games & Read More
Two new RAND studies examine cannabis use, spending, enforcement, and policy options in Indiana, one of the few states where Read More
Indiana has some of the strictest cannabis laws and has no medical cannabis industry yet allows the largely unregulated retail Read More
“This legislation sets an important precedent for protecting licensed professionals from unjust discipline while respecting the will of Maryland voters Read More
This past week, I woke up to cannabis being rescheduled. Could it be? Did the powers that be finally do Read More
Rescheduling aligns with Avicanna’s established pharmaceutical and medical cannabis strategyRescheduling further supports advancement of R&D, clinical development, and Read More
The Department of Justice issued an order on April 23, rescheduling state-licensed medical marijuana and Food & Drug Administration-approved cannabis products Read More
Wall Street is starting to price who can actually deliver rare earth supply inside the United States, not just extract Read More
Beau Kilmer oversees RAND’s research on psychedelic use and policy which informs conversations on the topic and helps decisionmakers Read More